Two Sigma Investments’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.2M | Sell |
27,528
-2,400
| -8% | -$368K | ﹤0.01% | 2126 |
|
|
2025
Q4 | $4.13M | Sell |
29,928
-1,800
| -6% | -$236K | 0.01% | 1883 |
|
|
2025
Q3 | $4.07M | Sell |
31,728
-302,771
| -91% | -$36.9M | 0.01% | 1610 |
|
|
2025
Q2 | $40.5M | Buy |
334,499
+254,389
| +318% | +$28.7M | 0.07% | 338 |
|
|
2025
Q1 | $8.93M | Buy |
80,110
+25,821
| +48% | +$2.75M | 0.02% | 810 |
|
|
2024
Q4 | $5.28M | Buy |
54,289
+25,915
| +91% | +$2.76M | 0.01% | 1070 |
|
|
2024
Q3 | $3.26M | Sell |
28,374
-128,038
| -82% | -$14.5M | 0.01% | 1338 |
|
|
2024
Q2 | $16.7M | Sell |
156,412
-4,997
| -3% | -$502K | 0.04% | 522 |
|
|
2024
Q1 | $15.6M | Buy |
161,409
+31,938
| +25% | +$3.27M | 0.04% | 515 |
|
|
2023
Q4 | $13.1M | Buy |
+129,471
| New | +$12.5M | 0.03% | 570 |
|
|
2023
Q2 | – | Sell |
-137,347
| Closed | -$12.6M | – | 3193 |
|
|
2023
Q1 | $12.6M | Sell |
137,347
-514,595
| -79% | -$44.9M | 0.04% | 506 |
|
|
2022
Q4 | $59.1M | Sell |
651,942
-546,053
| -46% | -$46M | 0.19% | 138 |
|
|
2022
Q3 | $91.1M | Sell |
1,197,995
-409,537
| -25% | -$33.9M | 0.31% | 81 |
|
|
2022
Q2 | $136M | Sell |
1,607,532
-324,422
| -17% | -$28.5M | 0.45% | 47 |
|
|
2022
Q1 | $170M | Buy |
1,931,954
+133,629
| +7% | +$11.6M | 0.5% | 28 |
|
|
2021
Q4 | $157M | Buy |
1,798,325
+36,833
| +2% | +$3.06M | 0.34% | 65 |
|
|
2021
Q3 | $144M | Buy |
1,761,492
+190,151
| +12% | +$17.1M | 0.32% | 69 |
|
|
2021
Q2 | $143M | Buy |
+1,571,341
| New | +$140M | 0.33% | 55 |
|
|
2020
Q3 | – | Sell |
-67,849
| Closed | -$5.93M | – | 3415 |
|
|
2020
Q2 | $5.93M | Sell |
67,849
-242,498
| -78% | -$20.9M | 0.03% | 584 |
|
|
2020
Q1 | $25.6M | Buy |
+310,347
| New | +$27.7M | 0.21% | 94 |
|
|
2018
Q4 | – | Sell |
-161,923
| Closed | -$12.5M | – | 3362 |
|
|
2018
Q3 | $12.5M | Sell |
161,923
-661,357
| -80% | -$48.9M | 0.03% | 568 |
|
|
2018
Q2 | $55.7M | Buy |
823,280
+314,807
| +62% | +$21.7M | 0.17% | 157 |
|
|
2018
Q1 | $36.8M | Buy |
+508,473
| New | +$38.7M | 0.12% | 205 |
|
|
2017
Q4 | – | Sell |
-6,928
| Closed | -$533K | – | 3352 |
|
|
2017
Q3 | $533K | Sell |
6,928
-37,347
| -84% | -$2.82M | ﹤0.01% | 2108 |
|
|
2017
Q2 | $3.31M | Sell |
44,275
-157,460
| -78% | -$11.2M | 0.01% | 1091 |
|
|
2017
Q1 | $13.4M | Buy |
+201,735
| New | +$13.4M | 0.05% | 508 |
|
|
2016
Q4 | – | Sell |
-63,570
| Closed | -$4.5M | – | 3395 |
|
|
2016
Q3 | $4.5M | Buy |
+63,570
| New | +$4.63M | 0.02% | 933 |
|
|
2016
Q2 | – | Sell |
-197,894
| Closed | -$12.8M | – | 3133 |
|
|
2016
Q1 | $12.8M | Buy |
197,894
+139,302
| +238% | +$9.48M | 0.06% | 370 |
|
|
2015
Q4 | $4.52M | Sell |
58,592
-243,378
| -81% | -$19.3M | 0.02% | 699 |
|
|
2015
Q3 | $24.9M | Buy |
301,970
+39,038
| +15% | +$3.47M | 0.13% | 194 |
|
|
2015
Q2 | $23.2M | Buy |
262,932
+232,831
| +773% | +$21.4M | 0.11% | 225 |
|
|
2015
Q1 | $2.66M | Buy |
+30,101
| New | +$2.67M | 0.01% | 1013 |
|
|
2014
Q4 | – | Sell |
-10,912
| Closed | -$920K | – | 2334 |
|
|
2014
Q3 | $920K | Buy |
+10,912
| New | +$883K | ﹤0.01% | 1080 |
|
|
2014
Q1 | – | Sell |
-95,612
| Closed | -$6.89M | – | 2174 |
|
|
2013
Q4 | $6.89M | Buy |
+95,612
| New | +$6.65M | 0.04% | 532 |
|
|
2013
Q3 | – | Sell |
-486,033
| Closed | -$30.8M | – | 2025 |
|
|
2013
Q2 | $30.8M | Buy |
+486,033
| New | +$31.6M | 0.22% | 124 |
|
Other funds holding NVS
Two Sigma Investments's NVS Position: Q1 2026 in Review
Two Sigma Investments reduced its Novartis (NVS) stake by 8% in Q1 2026, selling an estimated $368K and leaving 27,528 shares worth $4.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2126.
Two Sigma Investments first reported a position in NVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $170M in Q1 2022. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Two Sigma Investments held 27,528 shares of Novartis worth $4.2M as of Q1 2026.
- Two Sigma Investments sold 2,400 Novartis shares in Q1 2026, an estimated $368K.
- Novartis made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2126 holding.
- Two Sigma Investments first reported a position in Novartis in Q2 2013 and has held it in 35 quarters since.
- Two Sigma Investments's Novartis position peaked at $170M in Q1 2022.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.